Confounder Adjustment Using the Disease Risk Score: A Proposal for Weighting Methods

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Confounder Adjustment Using the Disease Risk Score : A Proposal for Weighting Methods. / Nguyen, Tri-Long; Debray, Thomas P A; Youn, Bora; Simoneau, Gabrielle; Collins, Gary S.

I: American Journal of Epidemiology, Bind 193, Nr. 2, 2024, s. 377–388.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nguyen, T-L, Debray, TPA, Youn, B, Simoneau, G & Collins, GS 2024, 'Confounder Adjustment Using the Disease Risk Score: A Proposal for Weighting Methods', American Journal of Epidemiology, bind 193, nr. 2, s. 377–388. https://doi.org/10.1093/aje/kwad196

APA

Nguyen, T-L., Debray, T. P. A., Youn, B., Simoneau, G., & Collins, G. S. (2024). Confounder Adjustment Using the Disease Risk Score: A Proposal for Weighting Methods. American Journal of Epidemiology, 193(2), 377–388. https://doi.org/10.1093/aje/kwad196

Vancouver

Nguyen T-L, Debray TPA, Youn B, Simoneau G, Collins GS. Confounder Adjustment Using the Disease Risk Score: A Proposal for Weighting Methods. American Journal of Epidemiology. 2024;193(2):377–388. https://doi.org/10.1093/aje/kwad196

Author

Nguyen, Tri-Long ; Debray, Thomas P A ; Youn, Bora ; Simoneau, Gabrielle ; Collins, Gary S. / Confounder Adjustment Using the Disease Risk Score : A Proposal for Weighting Methods. I: American Journal of Epidemiology. 2024 ; Bind 193, Nr. 2. s. 377–388.

Bibtex

@article{71ae630bc4c9436d9e8928d222ef5d10,
title = "Confounder Adjustment Using the Disease Risk Score: A Proposal for Weighting Methods",
abstract = "Propensity score analysis is a common approach to addressing confounding in non-randomized studies. Its implementation, however, requires important assumptions (e.g., positivity). The disease risk score is an alternative confounding score that can relax some of these assumptions. Like the propensity score, the disease risk score summarizes multiple confounders into a single score, on which conditioning by matching allows the estimation of causal effects. However, matching relies on arbitrary choices for pruning out data (e.g., matching ratio, algorithm and caliper width) and may be computationally demanding. Alternatively, weighting methods, common in propensity score analysis, are easy to implement and may entail fewer choices, yet none have been developed for the disease risk score. We present two weighting approaches: one derives directly from inverse probability weighting (IPW); the other named target distribution weighting (TDW) relates to importance sampling. We empirically show IPW and TDW display a performance comparable to matching techniques in terms of bias but outperform them in terms of efficiency (mean squared error) and computational speed (up to >870 times faster in an illustrative study). We illustrate implementation of the methods in two case studies where we investigate placebo treatments for multiple sclerosis and administration of Aspirin in stroke patients.",
author = "Tri-Long Nguyen and Debray, {Thomas P A} and Bora Youn and Gabrielle Simoneau and Collins, {Gary S}",
year = "2024",
doi = "10.1093/aje/kwad196",
language = "English",
volume = "193",
pages = "377–388",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Confounder Adjustment Using the Disease Risk Score

T2 - A Proposal for Weighting Methods

AU - Nguyen, Tri-Long

AU - Debray, Thomas P A

AU - Youn, Bora

AU - Simoneau, Gabrielle

AU - Collins, Gary S

PY - 2024

Y1 - 2024

N2 - Propensity score analysis is a common approach to addressing confounding in non-randomized studies. Its implementation, however, requires important assumptions (e.g., positivity). The disease risk score is an alternative confounding score that can relax some of these assumptions. Like the propensity score, the disease risk score summarizes multiple confounders into a single score, on which conditioning by matching allows the estimation of causal effects. However, matching relies on arbitrary choices for pruning out data (e.g., matching ratio, algorithm and caliper width) and may be computationally demanding. Alternatively, weighting methods, common in propensity score analysis, are easy to implement and may entail fewer choices, yet none have been developed for the disease risk score. We present two weighting approaches: one derives directly from inverse probability weighting (IPW); the other named target distribution weighting (TDW) relates to importance sampling. We empirically show IPW and TDW display a performance comparable to matching techniques in terms of bias but outperform them in terms of efficiency (mean squared error) and computational speed (up to >870 times faster in an illustrative study). We illustrate implementation of the methods in two case studies where we investigate placebo treatments for multiple sclerosis and administration of Aspirin in stroke patients.

AB - Propensity score analysis is a common approach to addressing confounding in non-randomized studies. Its implementation, however, requires important assumptions (e.g., positivity). The disease risk score is an alternative confounding score that can relax some of these assumptions. Like the propensity score, the disease risk score summarizes multiple confounders into a single score, on which conditioning by matching allows the estimation of causal effects. However, matching relies on arbitrary choices for pruning out data (e.g., matching ratio, algorithm and caliper width) and may be computationally demanding. Alternatively, weighting methods, common in propensity score analysis, are easy to implement and may entail fewer choices, yet none have been developed for the disease risk score. We present two weighting approaches: one derives directly from inverse probability weighting (IPW); the other named target distribution weighting (TDW) relates to importance sampling. We empirically show IPW and TDW display a performance comparable to matching techniques in terms of bias but outperform them in terms of efficiency (mean squared error) and computational speed (up to >870 times faster in an illustrative study). We illustrate implementation of the methods in two case studies where we investigate placebo treatments for multiple sclerosis and administration of Aspirin in stroke patients.

U2 - 10.1093/aje/kwad196

DO - 10.1093/aje/kwad196

M3 - Journal article

C2 - 37823269

VL - 193

SP - 377

EP - 388

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 2

ER -

ID: 369872377